September 14th, 2006, News update for 2nd quarter of 2006

April 2006, Peru: launch of Pylopac, original tri-therapy dosage pack licensed by Medley (Brazil) for eradication of infections caused by Helicobacter pylori in patients with gastric and/or duodenal ulcer.
For more info: http://www.rpp.com.pe/portada/agenda_empresarial/38508_1.php

May  2006, Switzerland :  signature of licensing agreement with Angelini A.C.R.A.F. Italy for Unidrox ( prulifloxacin),  a new patented antibacterial agent of the fluoroquinolone group indicated in acute cystitis and acute exacerbation of chronic bronchitis.
For more info: http://www.angelini.it/public/schedepharma/unidrox.htm

June 2006, Portugal: launch of Mictonorm, indicated in urinary incontinence. Mictonorm (propiverine), manufactured under license of APOGEPHA (Germany) benefits from a dual mode of action with anticholinergic and calcium-antagonistic properties.